damage – Page 3 – Communicable Diseases Research

Blood Viscosity in COVID-19 Patients With Sudden Deafness

급성 난청이 있는 COVID-19 환자의 혈액 점도

Article

Published on 2022-03-012022-09-11
Journal: Acta otorrinolaringologica española [Category] COVID19(2023년), SARS, 치료기술,

Successful Reversal of the 2020 Covid-19 Response Induced Collateral Damage on Malaria Control in Saudi Arabia

Conference abstract

Published on 2022-03-012022-10-05
Journal: International Journal of Infectious Diseases [Category] 유전자 메커니즘,

COVID-19-specific metabolic imprint yields insights into multiorgan system perturbations

COVID-19 관련 대사 흔적은 다기관 시스템 섭동에 대한 통찰력을 제공합니다

Article

Published on 2022-03-012022-09-11
Journal: European Journal of Immunology [Category] MERS, SARS, 유전자 메커니즘, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Affect aligned alteration capture cellular circulating metabolome Comorbidities Comorbidity confounding factor Corona Coronavirus-2 COVID-19 COVID-19 severity damage defined disease driven by hospitalized COVID-19 patient immune activation immunological immunology indicated Inflammation integration metabolite metabolome metabolomics molecular multi Multi-omics Multiorgan multiple pathway multiple pathways network Neuroinflammation neurological organ damage organ systems performed Perturbation perturbations proteomic question recent resource respiratory SARS-CoV-2 Seroconversion severe acute respiratory syndrome Coronavirus severe COVID-19 patients severity switch trajectory unique
[DOI] 10.1002/eji.202149626 PMC 바로가기 [Article Type] Article

Delta Variant with P681R Critical Mutation Revealed by Ultra-Large Atomic-Scale Ab Initio Simulation: Implications for the Fundamentals of Biomolecular Interactions

초대형 원자 규모 Ab 초기 시뮬레이션으로 밝혀진 P681R 치명적 돌연변이가 있는 델타 변이체: 생체 분자 상호 작용의 기본 사항에 대한 의미

Article

Published on 2022-02-242022-09-11
Journal: Viruses [Category] COVID19(2023년), SARS, 변종,

Obstetric outcomes in pregnant COVID-19 women: the imbalance of von Willebrand factor and ADAMTS13 axis

임신 한 Covid-19 여성의 산과 적 결과 : Von Willebrand Factor and Adamts13 축의 불균형

Observational Study

Published on 2022-02-212022-09-10
Journal: BMC Pregnancy and Childbirth [Category] COVID19(2023년), Fulltext, MERS, SARS, 바이오마커, 유전자 메커니즘, 임상,

[키워드] 95%CI AB0 blood group system ADA ADAMTS13 Admission adverse outcomes age association Asymptomatic Biomarker clinical information clinical outcomes collected confounders COVID-19 COVID-19 patient COVID-19 patients damage Decision making decision making process demographic diagnosis of SARS-CoV-2 discharge evaluate Follow-up gestational age hospital Hospital admission Imbalance independent Infection investigated Italy laboratory data laboratory parameter Laboratory parameters laboratory-confirmed Logistic regression Logistic regression analysis marker mechanism median microangiopathy monitoring outcome Pregnancy pregnant pregnant women preterm delivery regression analysis responsible Result risk SARS-COV-2 infection significantly significantly higher significantly lower Support Symptom symptom of infection thrombotic microangiopathy von Willebrand factor was performed with COVID-19
[DOI] 10.1186/s12884-022-04405-8 PMC 바로가기 [Article Type] Observational Study

An In Vivo Observational Histological Study of Peripheral Arterial Damage in Patients with Acute Limb Ischemia in SARS-CoV-2 Infection

Article

Published on 2022-02-142022-10-31
Journal: Diagnostics [Category] COVID-19,

Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal

COVID-19 초기의 가정 약물 치료로 입원 예방 및 사망률 감소: 적절한 제안이 필요한 시점

Review

Published on 2022-02-012022-09-11
Journal: Basic & clinical pharmacology & toxicology [Category] COVID19(2023년), SARS, 치료제,

A new infodemiological approach through Google Trends: longitudinal analysis of COVID-19 scientific and infodemic names in Italy

Google 트렌드를 통한 새로운 불화학 적 접근

Research

Published on 2022-01-302022-09-10
Journal: BMC Medical Research Methodology [Category] Fulltext, SARS, 변종,

Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis

긴 비 코딩 RNA (LNCRNA) NEAT1 및 MALAT1은 심각한 COVID-19 환자에서 차등 적으로 발현됩니다. 통합 된 단일 세포 분석

Research Article

Published on 2022-01-102022-09-10
Journal: PLoS ONE [Category] 유전자 메커니즘, 치료기술, 치료제,

[키워드] Analysis analyzed Apoptosis applied BAL Bronchoalveolar lavage Cell cell population cell stress cell types cellular stress response component coronavirus disease Coronavirus disease 2019 COVID-19 damage diagnostic differentially expressed differentiator disease severity dysregulation focus foster hallmark immune dysregulation immunomodulatory Inflammation Inflammatory involved lncRNA Long long non-coding RNA MALAT1 measure Mild mononuclear cell mononuclear cells NEAT1 non-coding RNA Patient PBMCs Peripheral blood Peripheral blood mononuclear cells pro-inflammatory function pro-inflammatory functions Regulation sequenced severe COVID-19 Severe patient severity single-cell single-cell RNA-seq dataset single-cell transcriptomic analysis stress response target targets therapy with COVID-19
[DOI] 10.1371/journal.pone.0261242 PMC 바로가기 [Article Type] Research Article

Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology

가용성 CD24를 사용한 치료는 COVID-19 관련 전신 면역병리를 약화시킵니다

Clinical Trial

Published on 2022-01-102022-09-12
Journal: Journal of Hematology & Oncology [Category] 임상, 진단,

[키워드] acute respiratory syndrome coronavirus Analysis anti-inflammatory agent anti-inflammatory agents Anti-viral Antibody Response approach attenuate binding blunt cause CD24 CD24Fc CD4 CD56 CD8 cellular compartments chemokine chemokines Clinical characteristics Clinical efficacy coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 severity cytokine Cytokine score Cytokines damage damage-associated molecular pattern Damage-associated molecular patterns demonstrated downstream enrolled epithelial cells Extracellular flow cytometry heat shock proteins homeostasis homology Immune homeostasis immunopathology Immunophenotyping induce infected individuals Inflammatory response Lung epithelial cells Natural killer cells Pathogenesis pathway Patient patients with COVID-19 performed Peripheral blood peripheral blood samples phosphatase placebo group pro-inflammatory cytokine Protein Randomized Release respiratory Result return SARS-CoV-2 SARS-CoV-2-infected individuals severe acute respiratory syndrome coronavirus 2 severe COVID-19 severity shown Siglec10 significantly Soluble CD24 supplementary material systemic cytokine response systemic inflammation T cell T cells therapeutic therapeutic efficacy Treatment Trial with COVID-19
[DOI] 10.1186/s13045-021-01222-y PMC 바로가기 [Article Type] Clinical Trial